NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Purple Biotech Ltd (TA: KTOV)

 
KTOV Technical Analysis
5
As on 8th Jun 2025 KTOV SHARE Price closed @ 4.40 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 20.04 & Strong Sell for SHORT-TERM with Stoploss of 29.55 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

KTOVSHARE Price

Open 4.60 Change Price %
High 4.60 1 Day 0.00 0.00
Low 4.40 1 Week 0.20 4.76
Close 4.40 1 Month -0.70 -13.73
Volume 246547 1 Year -27.90 -86.38
52 Week High 36.70 | 52 Week Low 4.00
 
TA Israel Most Active Stocks
TA125 2008.05 1.06%
BLRX 3.40 25.93%
DSCT 2968.00 1.75%
ORL 89.90 -0.55%
CANF 1.40 0.00%
ICL 2371.00 1.85%
TDGN-L 171.50 17.55%
FRSX 7.10 2.90%
GIX 33.60 -6.93%
ALMO 33.60 -6.93%
 
TA Israel Top Gainers Stocks
INFR 3400.00 33.07%
BLRX 3.40 25.93%
BLRX 3.40 25.93%
TDGN-L 171.50 17.55%
MCRNT 372.50 16.84%
LBTL 1138.00 10.70%
CNMD 45.10 10.54%
CNMD 45.10 10.54%
GIVO-L 29.50 10.07%
BIRM 1144.00 8.75%
 
TA Israel Top Losers Stocks
KMNK 51.00 -23.19%
ULTR 74.10 -16.74%
MEAT 0.77 -9.41%
MEAT 0.77 -9.41%
MYSZ 153.90 -8.66%
MYSZ 153.90 -8.66%
LEOF 444.00 -7.11%
GIX 33.60 -6.93%
GIX 33.60 -6.93%
ALMO 33.60 -6.93%
 
 
KTOV
Daily Charts
KTOV
Intraday Charts
Whats New @
Bazaartrend
KTOV
Free Analysis
 
KTOV Important Levels Intraday
RESISTANCE4.79
RESISTANCE4.66
RESISTANCE4.59
RESISTANCE4.51
SUPPORT4.29
SUPPORT4.21
SUPPORT4.14
SUPPORT4.01
 
KTOV Forecast June 2025
4th UP Forecast27.14
3rd UP Forecast19.85
2nd UP Forecast15.34
1st UP Forecast10.83
1st DOWN Forecast-2.03
2nd DOWN Forecast-6.54
3rd DOWN Forecast-11.05
4th DOWN Forecast-18.34
 
KTOV Weekly Forecast
4th UP Forecast24.83
3rd UP Forecast18.28
2nd UP Forecast14.23
1st UP Forecast10.18
1st DOWN Forecast-1.38
2nd DOWN Forecast-5.43
3rd DOWN Forecast-9.48
4th DOWN Forecast-16.03
 
KTOV Forecast2025
4th UP Forecast68.38
3rd UP Forecast47.86
2nd UP Forecast35.18
1st UP Forecast22.49
1st DOWN Forecast-13.69
2nd DOWN Forecast-26.38
3rd DOWN Forecast-39.06
4th DOWN Forecast-59.58
 
 
KTOV Other Details
Segment EQ
Market Capital 227007808.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
KTOV Address
KTOV
 
KTOV Latest News
 
Your Comments and Response on Purple Biotech Ltd
 
KTOV Business Profile
Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs. It operates through two segments, Oncology, and Pain and Hypertension. The company's marketed products include Consensi, a fixed-dose combination of celecoxib and amlodipine besylate for the simultaneous treatment of osteoarthritis pain and hypertension in the United States, as well as in China and South Korea. Its oncology pipeline includes NT-219, a small molecule that is advancing as a monotherapy treatment of advanced solid tumors and in combination with cetuximab for the treatment of recurrent or metastatic squamous cell carcinoma of head and neck cancer in a planned phase 1/2 study; and CM-24, a monoclonal antibody blocking CEACAM1 that is being developed as a combination therapy with anti-PD1 checkpoint inhibitors for the treatment of non-small cell lung cancer and pancreatic cancer. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. Purple Biotech Ltd. is headquartered in Tel Aviv, Israel. Address: One Azrieli Center, Tel Aviv, Israel, 6701101
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service